Brachytherapy and continuous infusion 5-fluorouracil for the treatment of locally advanced, lymph node negative, prostate cancer: A phase I trial

Cancer

Volumn 77, Issue 5, 1996, Pages 924-927

  See, William A ^a   Dreicer, Robert ^a   Wheeler, James A ^a   Forest, Paula K ^a   Loening, Stefan ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

5 fluorouracil; brachytherapy; infusion; prostatic neoplasms; radiosensitizer

Indexed keywords

FLUOROURACIL; GOLD 198;

ADULT; AGED; ANTIGEN DETECTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER STAGING; CLINICAL TRIAL; CONTINUOUS INFUSION; CYSTITIS; HUMAN; INTERSTITIAL RADIATION; INTRAVENOUS DRUG ADMINISTRATION; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NAUSEA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE CANCER; RADIOSENSITIZATION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS; BRACHYTHERAPY; COMBINED MODALITY THERAPY; FLUOROURACIL; GOLD RADIOISOTOPES; HUMANS; INFUSIONS, INTRAVENOUS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE;

EID: 0030047318     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19960301)77:5<924::AID-CNCR18>3.0.CO;2-5     Document Type: Article

References (31)

1. Walsh PC, Partin AW, Epstein JI. Cancer control and quality of life following anatomical radical retropubic prostatectomy: result at 10 years. J Urol 1994; 152:1831-6.
2. Trappasso JG, DeKernion JB, Smith RB, Dorey F. The incidence and significance of detectable levels of serum prostate specific antigen after radical prostatectomy. J Urol 1994; 152:1821-5.
3. Zeitman AL, Shipley WU, Coen JJ. Radical prostatectomy and radical radiation therapy for clinical T1 to T2 adenocarcinoma of the prostate: new insights into outcome from repeat biopsy and prostate specific antigen. J Urol 1994; 152:1806-12.
4. Porter AT, Forman JD. Prostate brachytherapy: an overview. Cancer 1993;71:953-8.
5. Porter AT, Blasko JC, Grimm PD, Reddy SM, Ragde H, Brachytherapy for prostate cancer. CA Cancer J Clin 1995;45:165-78.
6. Vokes EE, Weichselbaum RR. Concomitant chemoradiotherapy: rationale and clinical experience in patients with solid tumors. J Clin Oncol 1990;8:911-34.
7. Hansen R, Moynihan T, Beatty P, Libnoch J, Schulte W, Anderson T. Continuous systemic 5-fluorouracil infusion in refractory prostatic cancer Urology 1991;37:358-61.
8. Kuzel TM, Tallman MS, Shevrin D. A Phase II study of continuous infusion 5-fluorouracil in advanced hormone refractoy prostate cancer: an Illinois Cancer Center Study. Cancer 1993;72:1965-8.
9. Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ: Manual for Staging of Cancer. 4th edition. American Joint Committee on Cancer. Philadelphia: JB Lippincott Co., 1992.
10. Turner JW, Loening SA. Improved technique for placement of interstitial brachytherapy in the treatment of prostate cancer: simultaneous high-resolution fluoroscopy and transrectal ultrasound. J Endourol 1992;6:67-71.
11. 198 implants of the prostate. Radiology 1992: 184:275-9.
12. Stein TA, Bailey B, Bums GP. Comparison of 5-fluorouracil anabolite levels after intravenous bolus and continuous infusion. Cancer Chemother Pharmacol 1994;34:292-6.
13. Anderson N, Lokich JJ. Cancer chemotherapy and infusional scheduling. Oncology 1994;8:99-116.
14. O'Connell M, Martenson J, Rich T, Wieand H, Krook J, Macdonald J, et al. Protracted venous infusion 5-fluorouracil as a component of effective combined modality postoperative surgical adjuvant therapy for high risk rectal cancer. Proc Am Soc Clin Oncol 1993;12(564):193.
15. Atkins JN, Muss HB, Case D, Brockschmidt J, Schnell FM, O'Rourke M, et al. High-dose 24-hour infusion of 5-fluorouracil in metastatic prostate cancer. Am J Clin Oncol 1991; 14:526-9.
16. Vermund H, Hodgett J, Ansfield FJ. Effects of combined irradiation and chemotherapy on transplanted tumors in mice. AJR Am J Roentgenol 1961;85:559-67.
17. Berry RJ. Effects of some metabolic inhibitors on x-ray dose-response curves for the survival of mammalian cells in vitro, and on early recovery between fractionated x-ray doses. Br J Radiol 1966;39:458-63.
18. Hughes LL, Luengas J, Rich TA, Murray D. Radiosenstitization of cultured human colon adenocarcinoma cells by 5-fluorouricil: effects on cell survival, DNA repair, and cell recovery. Int J Radiat Oncol Biol Phys 1992; 23:983-91.
19. Rich TA. Chemoradiation for gastrointestinal cancer. Front Radiat Ther Oncol 1992;26:115-30.
20. Rich TA. Protracted (continuous 5-fluorouracil) infusion with concomitant radiation therapy: indications and results. In: Rotman M, Rosenthal CJ, editors. Medical radiology concomitant continuous infusion chemotherapy and radiation. Berlin: Springer-Verlag, 1991:181-8.
21. Rich TA, Evans DB, Curley SA, Ajani JA. Adjuvant radiotherapy for biliary and pancreatic cancer. Ann Oncol 1994; 5:S75-S80.
22. Coia LR, Engstrom PF, Paul AR, Stafford PM, Hanks GE. Long-term results of infusional 5-FU, mitomycin-C, and radiation as primary management of esophageal carcinoma. Int J Radiat Oncol Biol Phys 1991;20:29-36.
23. Whittington R, Neuberg D, Tester WJ, Benson AB III, Haller DG. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pacreaticobiliary carcinoma: a phase I Eastern Cooperative Oncology Group trial. J Clin Oncol 1995;13:227-32.
24. Khan FM. The physics of radiation therapy. 2nd edition. Baltimore: Williams & Wilkins. 1994.
25. Dawson JE, Wu T, Roy T, Gu JY, Kim H. Dose effects of seed placement deviations from pre-planned positions in ultrasound guided prostate implants. Radiother Oncol 1994;32:268-70.
26. Ling CC, Li WX, Anderson LL. The relative biological effectiveness of I-125 and Pd-103. Int J Radiat Oncol Biol Phys 1995;32:373-8.
27. Ling CC. Permanent implants using AU-198, Pd-103, and I-125: radiobiological considerations based on the linear quadratic model. Int J Radiat Oncol Biol Phys 1992;23:81-7.
28. Blasko JC, Grimm PD, Ragde H. Brachytherapy and organ preservation in the management of carcinoma of the prostate. Semin Radiat Oncol 1993;3:230-9.
29. Priestly JB, Beyer DC. Guided brachytherapy for treatment of confined prostate cancer. Urology 1992;40:27-32.
30. 125 implantation for carcinoma of the pancreas. Int J Radiat Oncol Biol Phys 1992;23:305-11.
31. Dinshaw KA, Sharma V, Pendse AM, Teland CS, Vege SS, Malliat MK, et al. The role of intraluminal radiotherapy and concurrent 5-fluorouracil infusion in the management of carcinoma esophagus: a pilot study. J Surg Oncol 1991; 47:155-60.